Centene Co. (NYSE:CNC) Director Theodore R. Samuels II Purchases 5,000 Shares of Stock

Centene Co. (NYSE:CNC) Director Theodore R. Samuels II acquired 5,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were bought at an average price of $58.86 per share, for a total transaction of $294,300.00. Following the completion of the transaction, the director now owns 23,000 shares of the company’s stock, valued at approximately $1,353,780. This trade represents a 27.78 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Centene Stock Performance

CNC stock opened at $57.81 on Wednesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Co. has a 1-year low of $55.03 and a 1-year high of $81.42. The business has a 50-day moving average price of $61.51 and a 200 day moving average price of $68.41. The company has a market capitalization of $29.18 billion, a P/E ratio of 10.04, a PEG ratio of 0.78 and a beta of 0.46.

Institutional Investors Weigh In On Centene

Several hedge funds have recently modified their holdings of CNC. Park Place Capital Corp lifted its holdings in Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after buying an additional 357 shares during the period. WR Wealth Planners LLC boosted its position in Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after purchasing an additional 137 shares in the last quarter. Chris Bulman Inc purchased a new position in Centene in the second quarter valued at about $33,000. Crewe Advisors LLC raised its holdings in Centene by 174.3% in the second quarter. Crewe Advisors LLC now owns 683 shares of the company’s stock worth $45,000 after purchasing an additional 434 shares in the last quarter. Finally, Private Trust Co. NA lifted its position in shares of Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after buying an additional 332 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Truist Financial decreased their price target on Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a report on Friday, December 13th. Wells Fargo & Company lowered their target price on shares of Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Robert W. Baird cut their price target on shares of Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a report on Friday, October 25th. Sanford C. Bernstein decreased their price objective on shares of Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a research note on Wednesday, October 30th. Finally, UBS Group raised Centene from a “neutral” rating to a “buy” rating and raised their price target for the stock from $79.00 to $80.00 in a research note on Friday, December 13th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $80.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.